We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Panel Discussion: Real-World Issues in CTD-PAH Screening, Diagnosis, and Management
Michael J. Cuttica, MD, MS
Victor Moles, MD
Vallerie V. McLaughlin, MD
Ruben Mylvaganam, MD
Screening, Diagnosis, and Treatment of PH-ILD
Case Study: A 62-Year-Old Male With CTEPH
George Hanna, MD
HFpEF – Diagnostic Approach Through Case Review
Yasmin Raza, MD
Epidemiology and Management of Left Heart Disease Associated PH
Thomas Cascino, MD
While DOACs are Good for Some Things, They Are Not for Everyone
M. Cecilia Bahit, MD
CTEPH & CTED -Current Epidemiology and Trends
Clinical Trials in HFpEF: What Have They Taught Us?
Ravi B. Patel, MD, MSc
The DOAC Revolution: What Have We Learned?
Christopher B. Granger, MD
Midwest Regional PH Summit – Management of Pulmonary Hypertension with Comorbidities
Daniel Schimmel, MD
Jonathan Haft, MD
Sydney Schacht, DO
New Frontiers in Anticoagulation: Factor XI/XIa Inhibitors
Manesh R. Patel, MD
Elaine Hylek, MD, MPH
Questions & Answers from the AHA 2023 Symposium
While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?
Overview of Major Changes to ERS/ESC Guidelines for PH
Balloon Pulmonary Angioplasty: Issues and Perspectives
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education